Your search returned 5 results.

Results
	1.	Rapid purification of a new humanized single-chain Fv antibody/human interleukin-2 fusion protein reactive against HER2 receptor. [electronic resource] by Zhang, Wei-Yun Yip, Tak-Chun Kwok, Cheuk-Sang Producer: 20050411 In: Acta biochimica et biophysica Sinica vol. 36 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Using a single parameter to describe time-activity curves. [electronic resource] by Kwok, Cheuk S Frankel, Paul H Lopatin, George Williams, Lawrence E Producer: 20141115 In: Cancer biotherapy & radiopharmaceuticals vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Pilot trial evaluating an 123I-labeled 80-kilodalton engineered anticarcinoembryonic antigen antibody fragment (cT84.66 minibody) in patients with colorectal cancer. [electronic resource] by Wong, Jeffrey Y C Chu, David Z Williams, Lawrence E Yamauchi, Dave M Ikle, David N Kwok, Cheuk S Liu, An Wilczynski, Sharon Colcher, David Yazaki, Paul J Shively, John E Wu, Anna M Raubitschek, Andrew A Producer: 20050307 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	A Phase I trial of 90Y-anti-carcinoembryonic antigen chimeric T84.66 radioimmunotherapy with 5-fluorouracil in patients with metastatic colorectal cancer. [electronic resource] by Wong, Jeffrey Y C Shibata, Stephen Williams, Lawrence E Kwok, Cheuk S Liu, An Chu, David Z Yamauchi, Dave M Wilczynski, Sharon Ikle, David N Wu, Anna M Yazaki, Paul J Shively, John E Doroshow, James H Raubitschek, Andrew A Producer: 20040727 In: Clinical cancer research : an official journal of the American Association for Cancer Research vol. 9 Availability: No items available. Save to lists Add to cart (remove)
	5.	A phase 1/2 trial of high-dose yttrium-90-ibritumomab tiuxetan in combination with high-dose etoposide and cyclophosphamide followed by autologous stem cell transplantation in patients with poor-risk or relapsed non-Hodgkin lymphoma. [electronic resource] by Nademanee, Auayporn Forman, Stephen Molina, Arturo Fung, Henry Smith, David Dagis, Andy Kwok, Cheuk Yamauchi, Dave Anderson, Anne-Line Falk, Peter Krishnan, Amrita Kirschbaum, Mark Kogut, Neil Nakamura, Ryotaro O'donnell, Margaret Parker, Pablo Popplewell, Leslie Pullarkat, Vinod Rodriguez, Roberto Sahebi, Firoozeh Smith, Eileen Snyder, David Stein, Anthony Spielberger, Ricardo Zain, Jasmine White, Christine Raubitschek, Andrew Producer: 20051107 In: Blood vol. 106 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)